Zimmer Biomet (ZBH): analysis and statistics
Return, volatility, Sharpe ratio and risk for Zimmer Biomet, a component of the S&P 500 in the Health Care sector. Data as of 2026-09-13.
| Last close price | $93.49 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | -7.33% |
| Total return over period | -20.30% |
| Annualized volatility | 27.18% |
| Period volatility | 46.92% |
| Sharpe ratio | -0.41 |
| Sortino ratio | -0.53 |
| Max drawdown | -38.82% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.23% |
| Correlation with the S&P 500 | 0.21 |
| Period range | $79.37 – $129.74 |
| Trading days analyzed | 751 |
Over the last 3.0 years, Zimmer Biomet (ZBH) has posted an annualized return of -7.33% with annual volatility of 27.18%, a negative Sharpe ratio: over this period it did not beat the risk-free Treasury rate. Its worst stretch (max drawdown from a peak) was -38.82%. Its correlation with the S&P 500 is 0.21, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how ZBH would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with ZBH →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Zimmer Biomet (ZBH) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio